Competitive intelligence

6sense Named a Leader in 11 G2 Spring 2022 Grid Reports

Retrieved on: 
Tuesday, March 22, 2022
Competitive intelligence, Organization, Orchestration, Conversion marketing, B2B, Leadership, Mark (given name), High performance organization, SAN, Terminology, Online gambling, Music, Mobile phone, Sales, G2

SAN FRANCISCO, March 22, 2022 /PRNewswire/ -- 6sense, the leading platform for B2B organizations generating predictable revenue, today announced that it has been named a Leader across 11 categories in the G2 Spring 2022 Grid Report. 6sense was also recognized as the number one ranked account-based advertising platform by customers for the sixth consecutive reporting period.The Leader designation signifies that 6sense has earned best-in-class ratings by verified customers for both customer satisfaction scores and market presence in each of the 11 categories. The high customer satisfaction score was reflected in feedback scores that included:

Key Points: 
  • SAN FRANCISCO, March 22, 2022 /PRNewswire/ -- 6sense , the leading platform for B2B organizations generating predictable revenue, today announced that it has been named a Leader across 11 categories in the G2 Spring 2022 Grid Report.
  • The Leader designation signifies that 6sense has earned best-in-class ratings by verified customers for both customer satisfaction scores and market presence in each of the 11 categories.
  • Slintel, a 6sense company, was also ranked as a Leader or High Performer in five shared categories with 6sense and ranked as a Leader in two additional unique categories, Lead Capture and Competitive Intelligence.
  • 6sense was listed as a Leader in 11 G2 Spring 2022 Grid categories:

Proactive Worldwide Launches the CI Learning Lab, the Next Evolution in Competitive Intelligence Training and Education

Retrieved on: 
Tuesday, March 15, 2022
Intelligence, Method, Competition, Partnership, SCIP, Strategic planning, Organization, Knowledge, The Lab, Learning, Fortune 500, Machine learning, Competitive intelligence, Education, PWW, Artificial intelligence, CI, CEO, Certification, Growth, Industry, Lab, Technology, Medicine, Management

The CI Learning Lab serves all CI skill levels, beginner to industry pro.

Key Points: 
  • The CI Learning Lab serves all CI skill levels, beginner to industry pro.
  • "The inaugural course in the CI Learning Lab, CI Blueprint, will teach individuals CI skills valuable to their careers and desired by their companies," says Proactive Worldwide Co-founder and CEO Gary Maag.
  • According to Maag's business partner, Proactive Worldwide Co-founder and President David Kalinowski, "CI is a great way to help company leaders grow their companies.
  • To learn more about the inaugural CI Blueprint course, read about it at the CI Learning Lab .

Iron Deficiency Anemia Market Insight, Epidemiology and Market Forecasts, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 3, 2022
Pharmaceutical, Health, Fitness & Nutrition, Table, United Kingdom, Therapy, Porter's five forces analysis, Epidemiology, News, SWOT, Anemia, Comprehension, Competition, Competitive intelligence, Acquisition, Growth–share matrix, Report, Technology, Red blood cell distribution width, PESTLE, Dietary supplement, Pharmaceutical industry

The "Iron Deficiency Anemia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Iron Deficiency Anemia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.
  • The Iron Deficiency Anemia market report provides current treatment practices, emerging drugs, Iron Deficiency Anemia market share of the individual therapies, current and forecasted Iron Deficiency Anemia market Size from 2019 to 2032 segmented by seven major markets.
  • The Iron Deficiency Anemia epidemiology division provide insights about historical and current Iron Deficiency Anemia patient pool and forecasted trend for every seven major countries.
  • The drug chapter segment of the Iron Deficiency Anemia report encloses the detailed analysis of Iron Deficiency Anemia marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

Semrush To Acquire Kompyte, Enhance Competitive Intelligence And Sales Enablement Capabilities

Retrieved on: 
Monday, February 28, 2022
Technology, Professional Services, Social Media, Search Engine Optimization, Search Engine Marketing, Blogging, Other Communications, Publishing, Public Relations, Investor Relations, Marketing, Other Technology, Advertising, Communications, Software, Other Professional Services, Internet, Data Management, Software as a service, Intelligence, Industry, Organization, Social media, NYSE, Martech, Acquisition, Corporate development, Competitive intelligence, Marketing, Automation, Technology, Solution, CEO, ARR, Risk management, Sales, Online shopping

Semrush (NYSE: SEMR), a leading online visibility management SaaS platform, today announces plans to acquire competitive intelligence automation and sales enablement platform Kompyte .

Key Points: 
  • Semrush (NYSE: SEMR), a leading online visibility management SaaS platform, today announces plans to acquire competitive intelligence automation and sales enablement platform Kompyte .
  • We believe Kompyte has had the best competitive intelligence technology in the industry, and now with the backing of a powerhouse like Semrush, we look forward to advancing our innovation and helping to ensure the highest value to our customers as, together, we redefine the Competitive Intelligence and sales enablement category.
  • The acquisition will also further extend the Semrush .Trends functionality, accelerating its competitive intelligence product offerings.
  • Kompyte is the perfect product to upsell to our existing customers who already use our competitive intelligence features, added Levin.

Global Sleep Apnea Markets, Forecast to 2032 - Data on Drugs, Sales, Shares, Epidemiology, Reimbursement Scenario, Unmet Needs, and More - ResearchAndMarkets.com

Retrieved on: 
Friday, February 25, 2022
Pharmaceutical, Health, Other Health, Comprehension, Therapy, Gaps, Awareness, Epidemiology, PESTLE, SWOT, Disease, Table, Acquisition, Growth–share matrix, Competition, Competitive intelligence, News, SME, Technology, Sleep apnea, Porter's five forces analysis, Lists of people executed in the United States, Research, Pharmaceutical industry, Marketing

The "Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
  • The Sleep Apnea market report provides current treatment practices, emerging drugs, Sleep Apnea market share of the individual therapies, current and forecasted Sleep Apnea market size from 2019 to 2032 segmented by seven major markets.
  • The Sleep Apnea epidemiology division provide insights about historical and current Sleep Apnea patient pool and forecasted trend for every seven major countries.
  • Drug chapter segment of the Sleep Apnea report encloses the detailed analysis of Sleep Apnea marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

Assessment of the Pneumonia Industry 2022: Insights, Epidemiology and Market Forecasts to 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 25, 2022
Infectious Diseases, General Health, Health, Comprehension, Therapy, Awareness, Epidemiology, PESTLE, SWOT, Disease, Table, KOL, Acquisition, Growth–share matrix, Competition, Competitive intelligence, News, SME, Technology, Porter's five forces analysis, Research, Vaccine, Pharmaceutical industry, Pneumonia, Phase II

The "Pneumonia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pneumonia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.
  • The Pneumonia market report provides current treatment practices, emerging drugs, Pneumonia market share of the individual therapies, current and forecasted Pneumonia market Size from 2019 to 2032 segmented by seven major markets.
  • The report also covers current Pneumonia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
  • The Pneumonia epidemiology division provide insights about historical and current Pneumonia patient pool and forecasted trend for every seven major countries.

Cystic Fibrosis - Global Industry, Epidemiology, and Competitive Landscape Assessment & Forecast to 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 25, 2022
Health, Pharmaceutical, Comprehension, Therapy, Cystic fibrosis, Awareness, Epidemiology, PESTLE, SWOT, Disease, Table, Acquisition, Growth–share matrix, Competition, Competitive intelligence, News, SME, Technology, Porter's five forces analysis, Lists of people executed in the United States, Research, Risk management, Management, Pharmaceutical industry, Marketing, Cyst

The "Cystic Fibrosis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cystic Fibrosis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
  • The Cystic fibrosis market report provides current treatment practices, emerging drugs, Cystic fibrosis market share of the individual therapies, current and forecasted Cystic fibrosis market size from 2019 to 2032 segmented by seven major markets.
  • The Cystic fibrosis epidemiology division provide insights about historical and current Cystic fibrosis patient pool and forecasted trend for every seven major countries.
  • Drug chapter segment of the Cystic fibrosis report encloses the detailed analysis of Cystic fibrosis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

Customer Experience Professionals Association Expands Leadership, Research, and Professional Certification

Retrieved on: 
Saturday, February 26, 2022
Customer experience, National Professional Practice Assessment, Lead, Telecom Egypt, National Social Security Fund (Uganda), Quadient, National Social Security Fund, Bayer, Solution, Australian Red Cross, Voice of the customer, Human, Board, Growth, CAE, University, Proprietary company, Johnson & Johnson, Leadership, CCXP, Element, Northumbrian Water, Customer, Prudential, Human voice, Volunteering, Director, CX, Interfaith Leadership Council of Metropolitan Detroit, Perception, National Social Investment Program, Association, Heart, Competitive intelligence, Technology, Certification, Management, Amazon, Knowledge, Finance, Walgreens

MINNEAPOLIS, Feb. 25, 2022 /PRNewswire-PRWeb/ -- The Customer Experience Professionals Association (CXPA) has announced an ambitious 2022 plan of work, supported by more than two hundred volunteers across the globe.

Key Points: 
  • MINNEAPOLIS, Feb. 25, 2022 /PRNewswire-PRWeb/ -- The Customer Experience Professionals Association (CXPA) has announced an ambitious 2022 plan of work, supported by more than two hundred volunteers across the globe.
  • CXPA continually prioritizes efforts to be an accessible, relevant, and respected community and resource for the professional practice of customer experience management.
  • Another top priority is the development of trusted, independent guidance on professional customer experience management practices.
  • A continuing priority for CXPA is administering the Certified Customer Experience Professional (CCXP) certification, which is held by 1,288 professionals worldwide.

Crayon’s Fifth Annual State of Competitive Intelligence Report Reveals Increased Investment in Competitive Intelligence as Competition Becomes Fiercer than Ever Before

Retrieved on: 
Wednesday, February 23, 2022
Marketing, Data Management, Advertising, Communications, Technology, Software, Intel, HubSpot, Intelligence, BattleCards, SCIP, Industry, Organization, Strategic and Competitive Intelligence Professionals, Competitive intelligence, CRM, Data collection, Dropbox, Technology, Automation, CEO, Research, Program, Time, Public relations, Crayon, Salesforce

Today, Crayon , the competitive intelligence backbone trusted by HubSpot, Dropbox, Gong, and Salesforce, announced the results of its 2022 State of Competitive Intelligence (CI) Report .

Key Points: 
  • Today, Crayon , the competitive intelligence backbone trusted by HubSpot, Dropbox, Gong, and Salesforce, announced the results of its 2022 State of Competitive Intelligence (CI) Report .
  • "This year's State of Competitive Intelligence report clearly shows this industry is at a positive inflection point," said Jonah Lopin, founder & CEO of Crayon.
  • Competition is up in every industry and the best firms are investing aggressively to build a sustainable competitive advantage in 2022."
  • Now is the time for competitive intelligence to shine, said Cam Mackey, the CEO of Strategic and Competitive Intelligence Professionals (SCIP).

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Global Industry Trends & Forecasts to 2032 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 18, 2022
Other Consumer, Hospitals, Biotechnology, Other Health, Health, Consumer, Pharmaceutical, Other Science, Science, Competitive intelligence, SME, Epidemiology, IPF, Growth–share matrix, Clinical trial, Porter's five forces analysis, Therapy, Technology, Competition, Lists of people executed in the United States, SWOT, Acquisition, Idiopathic pulmonary fibrosis, Table, PESTLE, News, Comprehension, Pharmaceutical industry, Marketing, Cough

This report delivers an in-depth understanding of the Cough in Idiopathic Pulmonary Fibrosis (IPF), historical and forecasted epidemiology as well as the Cough in Idiopathic Pulmonary Fibrosis (IPF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Key Points: 
  • This report delivers an in-depth understanding of the Cough in Idiopathic Pulmonary Fibrosis (IPF), historical and forecasted epidemiology as well as the Cough in Idiopathic Pulmonary Fibrosis (IPF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
  • The Cough in Idiopathic Pulmonary Fibrosis (IPF) market report provides current treatment practices, emerging drugs, Cough in Idiopathic Pulmonary Fibrosis (IPF) market share of the individual therapies, current and forecasted Cough in Idiopathic Pulmonary Fibrosis (IPF) market Size from 2019 to 2032 segmented by seven major markets.
  • The Cough in Idiopathic Pulmonary Fibrosis (IPF) epidemiology division provide insights about historical and current Cough in Idiopathic Pulmonary Fibrosis (IPF) patient pool and forecasted trend for every seven major countries.
  • Drug chapter segment of the Cough in Idiopathic Pulmonary Fibrosis (IPF) report encloses the detailed analysis of Cough in Idiopathic Pulmonary Fibrosis (IPF) marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.